Nitrase Therapeutics
Company

Nitrase Therapeutics

Biotechnology Research Brisbane, California, United States 22 employees
Employees
22
Contacts
4
Emails
4
Phones
2

Nitrase Therapeutics Overview

Headquarters
Brisbane, California, United States
Industry
Biotechnology Research
Employees
22
Founded
2018
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Nitrase Therapeutics

Nitrase Therapeutics is a pioneering biopharmaceutical company deploying its unique NITROME platform to unlock the therapeutic potential of nitrases, a new class of enzymes that it discovered, to develop a pipeline of therapies against a broad variety of diseases. The medicines that Nitrase Therapeutics is developing will target these enzymes and potentially help slow or halt the progression of a wide variety of diseases in which nitrases and nitro-substrates play a role, including Parkinson’s and cancer. Nitrase Therapeutics (under the former name Nitrome Biosciences) has been widely recognized and has won multiple awards including the prestigious Target Advancement grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF).

Nitrase Therapeutics Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Nitrase Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Carla Ramos Site Head, VP of Operations
Email Phone
Robert Blazej Partner at Mission Biocapital
Email Phone
Eric Yuen Biotechnology and Pharmaceutical
Email
Frank Kayser VP of Drug Discovery
Email

Employees by Management Level

VP / Head 2 profiles
Individual contributor 2 profiles

Compare Similar Companies to Nitrase Therapeutics